Supplemental material
Open access
296
Views
0
CrossRef citations to date
0
Altmetric
Hematology
Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data
Liliya Sinyavskayaa STATLOG Inc, Montreal, Canada
, Aster Mecheb Real World Evidence Center of Excellence, Pfizer Inc, New York, NY, USACorrespondence[email protected]
, Ariane Fauchera STATLOG Inc, Montreal, Canada
, Patrick Hlavacekc Value and Evidence, Pfizer Inc, New York, NY, USA
, Sarasa M. A. Johnsona STATLOG Inc, Montreal, Canada
, Marco DiBonaventurac Value and Evidence, Pfizer Inc, New York, NY, USA
, Francis Vekemana STATLOG Inc, Montreal, Canada
, Jinma Rend Statistical Research and Data Science Center, Pfizer Inc, Collegeville, PA, USA
& Alex Scheparte US Medical Affairs, Pfizer Inc, New York, NY, USA
show all
Pages 789-801
|
Received 03 Nov 2023, Accepted 15 Mar 2024, Published online: 12 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.